Journal of Occupational
Health and Epidemiology
Rafsanjan university Of medical sciences
Volume 13, Issue 1 (Winter 2024)
J Occup Health Epidemiol 2024, 13(1): 1-9 |
Back to browse issues page
Ethics code: . (Reference number: IR.SUMS.REC.1399.068)
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mirahmadizadeh A, Dehghani S S, Karimi M R, Moftakhar L. The Survival Rate and Its Related Factors in Hospitalized Covid-19 Patients in Fars Province in the South of Iran: A Hospital-Based Historical Cohort Study (2019 – 2022). J Occup Health Epidemiol 2024; 13 (1) :1-9
URL: http://johe.rums.ac.ir/article-1-727-en.html
URL: http://johe.rums.ac.ir/article-1-727-en.html
Related article in
Google Scholar
Google Scholar
Similar articles
1- Associate Prof., Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
2- Medical Doctor, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Medical Doctor, Technical Assistant of Health Vice Chancellor, Shiraz University of Medical Sciences, Shiraz, Iran.
4- Ph.D. in Epidemiology, Abadan University of Medical Sciences, Abadan, Iran ,moftakhar_p@yahoo.com
2- Medical Doctor, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Medical Doctor, Technical Assistant of Health Vice Chancellor, Shiraz University of Medical Sciences, Shiraz, Iran.
4- Ph.D. in Epidemiology, Abadan University of Medical Sciences, Abadan, Iran ,
Article history
Received: 2023/04/3
Accepted: 2024/01/28
ePublished: 2024/03/20
Accepted: 2024/01/28
ePublished: 2024/03/20
Subject:
Epidemiology
Abstract: (1068 Views)
Background: The outbreak of the Covid-19 has been a serious threat to the health and lives of many people. This study aimed to determine the survival rate and its contributing factors in Covid-19 patients who were hospitalized in hospitals in Fars province.
Materials and Methods: This study is a hospital-based carried out on 119429 of Covid-19 hospitalized patients in the south of Iran within 2019 – 2022. Information of demographics and clinical characteristics, symptoms, and comorbidity of patients were extracted from medical records. The Kaplan–Meier curve and the Log rank test were used to compare survival rate in different groups. Cox regression was employed to determine the factors that affect survival.
Results: The mean age of the participants was 51.5 year. The density incidence of death was estimated to be 16.8, 4.6, and 43.9 per 1000 person-days for all of patient, intensive care unit patients, and intubated patients, respectively. The Multiple Cox Regression results suggested that risk of mortality is 5.61 times higher in patients over 75 years, 3 times higher in patients admitted to the intensive care unit, and 3.4 times higher in intubated patients. Also, the risk of mortality was higher in men and those with underlying disease.
Conclusion: We found out that being elder, being a male, hospitalization in the intensive care unit, and being intubated would increase the risk of mortality. Thus, it is treatment management of hospitalized patients is necessary, especially elderly patients and those with underlying diseases.
Materials and Methods: This study is a hospital-based carried out on 119429 of Covid-19 hospitalized patients in the south of Iran within 2019 – 2022. Information of demographics and clinical characteristics, symptoms, and comorbidity of patients were extracted from medical records. The Kaplan–Meier curve and the Log rank test were used to compare survival rate in different groups. Cox regression was employed to determine the factors that affect survival.
Results: The mean age of the participants was 51.5 year. The density incidence of death was estimated to be 16.8, 4.6, and 43.9 per 1000 person-days for all of patient, intensive care unit patients, and intubated patients, respectively. The Multiple Cox Regression results suggested that risk of mortality is 5.61 times higher in patients over 75 years, 3 times higher in patients admitted to the intensive care unit, and 3.4 times higher in intubated patients. Also, the risk of mortality was higher in men and those with underlying disease.
Conclusion: We found out that being elder, being a male, hospitalization in the intensive care unit, and being intubated would increase the risk of mortality. Thus, it is treatment management of hospitalized patients is necessary, especially elderly patients and those with underlying diseases.
References
1. Ma X, Wang H, Huang J, Geng Y, Jiang S, Zhou Q, et al. A nomogramic model based on clinical and laboratory parameters at admission for predicting the survival of COVID-19 patients. BMC Infect Dis. 2020;20(1):899. [DOI] [PMID] [PMCID]
2. Salinas-Escudero G, Carrillo-Vega MF, Granados-García V, Martínez-Valverde S, Toledano-Toledano F, Garduño-Espinosa J. Correction to: A survival analysis of COVID-19 in the Mexican population. BMC Public Health. 2020;20(1):1831. [DOI] [PMID] [PMCID]
3. Eshrati B, Baradaran HR, Erfanpoor S, Mohazzab A, Moradi Y. Investigating the factors affecting the survival rate in patients with COVID-19: A retrospective cohort study. Med J Islam Repub Iran. 2020;34:88. [DOI] [PMID] [PMCID]
4. Santos MM, Lucena EES, Lima KC, Brito AAC, Bay MB, Bonfada D. Survival and predictors of deaths of patients hospitalised due to COVID-19 from a retrospective and multicentre cohort study in Brazil. Epidemiol Infect. 2020;148:e198. [DOI] [PMID] [PMCID]
5. Worldometer. COVID-19 Coronavirus Pandemic. United States of America. Worldometers; 2022. Available from: https://www.worldometers.info/coronavirus/
6. Murillo-Zamora E, Hernandez-Suarez CM. Survival in adult inpatients with COVID-19. Public Health. 2021;190:1-3. [DOI] [PMID] [PMCID]
7. Kaso AW, Agero G, Hurissa Z, Kaso T, Ewune HA, Hareru HE, et al. Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study. PLoS One. 2022;17(5):e0268280. [DOI] [PMID] [PMCID]
8. Oliveira E, Parikh A, Lopez-Ruiz A, Carrilo M, Goldberg J, Cearras M, et al. ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLoS One. 2021;16(3):e0249038. [DOI] [PMID] [PMCID]
9. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48(12):1503-10. [DOI] [PMID]
10. Sousa GJB, Garces TS, Cestari VRF, Florêncio RS, Moreira TMM, Pereira MLD. Mortality and survival of COVID-19. Epidemiol Infect. 2020;148:e123. [DOI] [PMID] [PMCID]
11. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. [DOI] [PMID] [PMCID]
12. Hewitt J, Carter B, Vilches-Moraga A, Quinn TJ, Braude P, Verduri A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):e444-51. [DOI] [PMID] [PMCID]
13. Ebrahimi V, Sharifi M, Mousavi-Roknabadi RS, Sadegh R, Khademian MH, Moghadami M, et al. Predictive determinants of overall survival among re-infected COVID-19 patients using the elastic-net regularized Cox proportional hazards model: a machine-learning algorithm. BMC Public Health. 2022;22(1):10. [DOI] [PMID] [PMCID]
14. Ferroni E, Giorgi Rossi P, Spila Alegiani S, Trifirò G, Pitter G, Leoni O, et al. Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID-19 Network. Clin Epidemiol. 2020;12:133746. [DOI] [PMID] [PMCID]
15. Bhandari S, Tak A, Singhal S, Shukla J, Shaktawat AS, Gupta J, et al. Patient flow dynamics in hospital systems during times of COVID-19: Cox proportional hazard regression analysis. Front Public Health. 2020;8:585850. [DOI] [PMID] [PMCID]
16. Altonen BL, Arreglado TM, Leroux O, Murray-Ramcharan M, Engdahl R. Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City. PLoS One. 2020;15(12):e0243343. [DOI] [PMID] [PMCID]
17. Boari GEM, Chiarini G, Bonetti S, Malerba P, Bianco G, Faustini C, et al. Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study. Biosci Rep. 2020;40(12):BSR20203455. [DOI] [PMID] [PMCID]
18. De Meester J, De Bacquer D, Naesens M, Meijers B, Couttenye MM, De Vriese AS, et al. Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a regionwide registry study. J Am Soc Nephrol. 2021;32(2):385-96. [DOI] [PMID] [PMCID]
19. Annweiler G, Corvaisier M, Gautier J, Dubée V, Legrand E, Sacco G, et al. Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study. Nutrients. 2020;12(11):3377. [DOI] [PMID] [PMCID]
20. Johnson HC, Gossner CM, Colzani E, Kinsman J, Alexakis L, Beauté J, et al. Potential scenarios for the progression of a COVID-19 epidemic in the European :union: and the European Economic Area, March 2020. Euro Surveill. 2020;25(9):2000202. [DOI] [PMID] [PMCID]
21. Lu W, Yu S, Liu H, Suo L, Tang K, Hu J, et al. Survival analysis and risk factors in COVID-19 patients. Disaster Med Public Health Prep. 2022:16(5):1916-21. [DOI] [PMID] [PMCID]
22. Riccardo F, Ajelli M, Andrianou XD, Bella A, Del Manso M, Fabiani M, et al. Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020. Euro Surveill. 2020;25(49):2000790. [DOI] [PMID] [PMCID]
23. Demichev V, Tober-Lau P, Nazarenko T, Lemke O, Kaur Aulakh S, Whitwell HJ, et al. A proteomic survival predictor for COVID-19 patients in intensive care. PLOS Digit Health. 2022;1(1):e0000007. [DOI] [PMID] [PMCID]
24. Wang Z, Ji JS, Liu Y, Liu R, Zha Y, Chang X, et al. Survival analysis of hospital length of stay of novel coronavirus (COVID-19) pneumonia patients in Sichuan, China. Medrxiv. 2020:2020-4. [DOI]
25. Del Rio C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. JAMA. 2020;323(14):1339-40. [DOI] [PMID]
26. Salvati L, Biagioni B, Vivarelli E, Parronchi P. A gendered magnifying glass on COVID-19. Clin Mol Allergy. 2020;18:14. [DOI] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution 4.0 International License. |
